GlassScriptPhysician profile
Abbas Naqvi
NPI 1861855900
$15,958.18
in general payments reported to CMS, 2019-2025
13 companies · $7,568 in 2025
The $7,568 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.92 · 2022: $521 · 2023: $322 · 2024: $7,461 · 2025: $7,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Food and Beverage: $2,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,626.89 |
| Food and Beverage | $2,724.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,121.32 | 2024-2025 | Journey II, Real Intelligence, Legion Revision |
| Linkbio Corp | $5,415.85 | 2024 | |
| Stryker Corporation | $3,503.88 | 2021-2025 | Mako, 1788, Orthomap |
| Zimmer Biomet Holdings, INC. | $416.29 | 2022-2024 | Persona, Dvr Anatomic Kickstand |
| Encore Medical, LP | $155.45 | 2022 | |
| Ortho Development Corporation | $141.57 | 2024 | |
| Heraeus Medical, LLC. | $76.99 | 2024 | |
| Supreme Orthopedic Systems, LLC | $26.77 | 2024 | |
| Integra Lifesciences Corporation | $25.40 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Microport Orthopedics INC | $22.61 | 2022 | |
| Think Surgical, INC. | $21.27 | 2024 | |
| Access Pro Medical, LLC | $17.98 | 2023 | Matriderm |
| Trice Medical, INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbas Naqvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.